Effects of bone disease and calcium supplementation on antioxidant enzymes in postmenopausal women

Clinical Biochemistry

Volumn 41, Issue 1-2, 2008, Pages 69-74

  Hahn, Marla ^a   Conterato, Greicy M M ^a   Frizzo, Clarissa P ^b   Augusti, Paula R ^b   da Silva, João C N ^a   Unfer, Tais C ^b   Emanuelli, Tatiana ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Centro de Ciencias Rurais   (Brazil)

Author keywords

Calcium supplementation; Catalase; Glutathione peroxidase; Osteopenia; Superoxide dismutase

Indexed keywords

CALCIUM; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; POSTMENOPAUSE; PRIORITY JOURNAL; SPECTROPHOTOMETRY; VITAMIN SUPPLEMENTATION;

AGED; ANTIOXIDANTS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CALCIUM, DIETARY; CASE-CONTROL STUDIES; CATALASE; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; SUPEROXIDE DISMUTASE;

EID: 36749008611     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.10.010     Document Type: Article

References (44)

1. Silbergeld E.K., and Flaws J.A. Chemicals and menopause: effects on age at menopause on health status in the postmenopausal period. J Women's Health 8 (1999) 227-233
2. Ferretti J.L., Cointry G.R., Capozza R.F., and Frost H.M. Bone mass, bone strength, muscle-bone interactions, osteopenia and osteoporosis. Mech Ageing Dev 24 (2003) 269-279
3. Kanis J.A., Melton III L.J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 9 (1994) 1137-1141
4. Gallagher J.C., Riggs B.L., and DeLuca H.F. Effects of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51 (1980) 1359-1364
5. Murray R.K., and Keeley F.W. The extracellular matrix: osteoporosis. In: Murray R.K., Granner D.K., Mayes P.A., and Rodwell V.W. (Eds). Harper's biochemistry (2000), McGraw-Hill, Stamford, Connecticut 710-711
6. Baylink D.J., Strong D.D., and Mohan S. The diagnosis and treatment of osteoporosis: future prospects. Mol Med Today 5 (1999) 133-140
7. Nordin B.E.C. Calcium and osteoporosis. Nutrition 13 (1997) 664-686
8. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23 (2002) 90-119
9. Basu S., Michaelsson K., Olofsson H., Johansson S., and Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288 (2001) 275-279
10. Maggio D., Barabani M., Pierandrei M., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88 (2003) 1523-1527
11. Lean J.M., Jagger C.J., Kirstein B., Fuller K., and Chambers T.J. Hydrogen peroxide essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146 (2005) 728-735
12. Datta H.K., Manning P., Rathod H., and McNeil C. Effect of calcitonin, elevated calcium and extracellular matrices on superoxide anion production by rat osteoclasts. Exp Physiol 80 (1995) 713-719
13. Datta H.K., Rathod H., Manning P., Turnbull Y., and McNeil C.J. Parathyroid hormone induces superoxide anion burst in the osteoclast: evidence for the direct instantaneous activation of the osteoclast by the hormone. J Endocrinol 149 (1996) 269-275
14. Van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-261
15. Fan X., Roy E., Zhu L., et al. Nitric oxide regulates receptor activator of nuclear factor-kB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145 (2004) 751-759
16. Ho W.P., Chen T.L., Chin W.Y., Ta Y.T., and Chen R.M. Nitric oxide induces osteoblast opoptosis through a mitochondria-dependent pathway. Ann NY Acad Sci 1042 (2005) 460-470
17. Das U.N. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp Biol Med 227 (2002) 88-93
18. Zhang J., Munger R.G., West N.A., Cutler D.R., Wengreen H.J., and Corcoran C.D. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol 163 (2006) 9-17
19. Wiseman H., O ́Reilly J.D., Adlercreutz H., et al. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72 (2000) 395-400
20. Viereck V., Grundker C., Blaschke S., Siggelkow H., Emons G., and Hofbauer L.C. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84 (2002) 725-735
21. Melhus H., Michaelsson K., Holmberg L., Wolk A., and Ljungahll S. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14 (1999) 129-135
22. Sontakke A.N., and Tare R.S. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 318 (2002) 145-148
23. Yalin S., Bagis S., Polat G., et al. Is there a role of free oxygen radicals in primary male osteoporosis?. Clin Exp Rheumatol 23 (2005) 689-692
24. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
25. McCord J., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244 (1969) 6049-6055
26. Aebi H. Catalase in vitro. Meth Enzymol 105 (1984) 121-126
27. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., and Yilmaz Z. Role of antioxidant systems, lipid peroxidation and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 295 (2007) 45-52
28. Yalin S., Bagis S., Aksit S.C., Arslan H., and Erdogan C. Effect of free radicals and antioxidants on postmenopausal osteoporosis. Asian J Chem 18 (2006) 1091-1096
29. Ozgocmen S., Kaya H., Fadillioglu E., and Yilmaz Z. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 38 (2007) 196-205
30. Inal M.E., Kanbak G., and Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 305 (2001) 75-80
31. 2). Biochem Biophys Res Commun 183 (1992) 1153-1158
32. Dreher I., Schutze N., Baur A., et al. Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 245 (1998) 101-107
33. Matés J.M., Pérez-Gómez C., and Castro I.N. Antioxidant enzymes and human diseases. Clin Biochem 32 (1999) 595-603
34. Kelner M.J., and Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistence. J Biol Chem 265 (1990) 10872-10875
35. Nogués M.R., Giralt M., Romeu M., et al. Melatonin reduces oxidative stress in erythrocytes and plasma of senescence-accelerated mice. J Pineal Res 41 (2006) 142-149
36. Brambilla L., Cairo G., Sestili P., O'Donnel V., Azzi A., and Cantoni O. Mitochondrial respiratory chain deficiency leads to overexpression of antioxidant enzymes. FEBS Lett 418 (1997) 247-250
37. Özden S., Dildar K., Kadir Y.H., and Gülizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 38 (2001) 165-170
38. Fuchs O. Effects of intracellular chelatable iron and oxidative stress on transcription of classical cellular glutathione peroxidase in murine erythroleucemia cells. Neoplasma 44 (1997) 184-191
39. Ay H., Topal T., Uysal B., et al. Time-dependent course of hyperbaric oxygen-induced oxidative effects in rat lung and erythrocytes. Clin Exp Pharmacol Physiol 34 (2007) 787-791
40. Sakalhoglu U., Aliyev E., Eren Z., Aksimsek G., Keskiner I., and Yavuz U. Arch Oral Biol 50 (2005) 1040-1046
41. Reid I.R., Ames R., Evans M.C., et al. Determination of total body and regional bone mineral density in normal postmenopausal women. A key role for fat mass. J Clin Endocrinol Metab 75 (1992) 45-51
42. Nordin B.E.C., Cleghorn D.B., Chatterton B.E., Morris H.A., and Need A.G. A 5-year longitudinal study of forearm bone mass in 307 postmenopausal women. J Bone Miner Res 8 (1993) 1427-1432
43. Weisman S.M., and Matkovic V. Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk. Clin Ther 27 (2005) 299-308
44. Kung A.W.C., Luk K.D.K., and Chiu P.K.Y. Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation. Am J Clin Nutr 68 (1998) 1291-1297